Australia · Delayed Price · Currency is AUD Acusensus Statistics
Total Valuation
Acusensus has a market cap or net worth of AUD 213.44 million. The enterprise value is 196.05 million.
| Market Cap | 213.44M |
| Enterprise Value | 196.05M |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Acusensus has 169.40 million shares outstanding. The number of shares has increased by 15.77% in one year.
| Current Share Class | 169.40M |
| Shares Outstanding | 169.40M |
| Shares Change (YoY) | +15.77% |
| Shares Change (QoQ) | +17.13% |
| Owned by Insiders (%) | 12.07% |
| Owned by Institutions (%) | 19.89% |
| Float | 117.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.48 |
| PB Ratio | 3.36 |
| P/TBV Ratio | 3.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.28 |
| EV / EBITDA | 42.87 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.26 |
| Quick Ratio | 2.13 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 1.66 |
| Debt / FCF | -0.39 |
| Interest Coverage | -10.16 |
Financial Efficiency
Return on equity (ROE) is -44.02% and return on invested capital (ROIC) is -11.09%.
| Return on Equity (ROE) | -44.02% |
| Return on Assets (ROA) | -3.79% |
| Return on Invested Capital (ROIC) | -11.09% |
| Return on Capital Employed (ROCE) | -6.92% |
| Weighted Average Cost of Capital (WACC) | 5.22% |
| Revenue Per Employee | 234,787 |
| Profits Per Employee | -66,188 |
| Employee Count | 367 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 22.83 |
Taxes
In the past 12 months, Acusensus has paid 182,000 in taxes.
| Income Tax | 182,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.41% in the last 52 weeks. The beta is 0.18, so Acusensus's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +30.41% |
| 50-Day Moving Average | 1.16 |
| 200-Day Moving Average | 1.45 |
| Relative Strength Index (RSI) | 56.67 |
| Average Volume (20 Days) | 248,753 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acusensus had revenue of AUD 86.17 million and -24.29 million in losses. Loss per share was -0.16.
| Revenue | 86.17M |
| Gross Profit | 36.16M |
| Operating Income | -5.12M |
| Pretax Income | -24.11M |
| Net Income | -24.29M |
| EBITDA | 1.20M |
| EBIT | -5.12M |
| Loss Per Share | -0.16 |
Balance Sheet
The company has 24.98 million in cash and 7.59 million in debt, with a net cash position of 17.39 million or 0.10 per share.
| Cash & Cash Equivalents | 24.98M |
| Total Debt | 7.59M |
| Net Cash | 17.39M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 63.58M |
| Book Value Per Share | 0.38 |
| Working Capital | 27.25M |
Cash Flow
In the last 12 months, operating cash flow was -2.98 million and capital expenditures -16.52 million, giving a free cash flow of -19.50 million.
| Operating Cash Flow | -2.98M |
| Capital Expenditures | -16.52M |
| Depreciation & Amortization | 6.32M |
| Net Borrowing | -3.23M |
| Free Cash Flow | -19.50M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 41.96%, with operating and profit margins of -5.94% and -28.19%.
| Gross Margin | 41.96% |
| Operating Margin | -5.94% |
| Pretax Margin | -27.98% |
| Profit Margin | -28.19% |
| EBITDA Margin | 1.39% |
| EBIT Margin | -5.94% |
| FCF Margin | n/a |
Dividends & Yields
Acusensus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.77% |
| Shareholder Yield | -15.77% |
| Earnings Yield | -11.38% |
| FCF Yield | -9.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Acusensus is 2.01, which is 57.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2.01 |
| Price Target Difference | 57.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 11.84% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 27, 2023. It was a forward split with a ratio of 5.
| Last Split Date | Jul 27, 2023 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Acusensus has an Altman Z-Score of 4.73 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.73 |
| Piotroski F-Score | 2 |